[
DCMC Session
|
]

Project Artemis: Building a Functioning & Sustainable Digital CMC Ecosystem

Learn how NASA-inspired Project Artemis sets the stage for CMC's own digital transformation "moonshot."

Meet the industry-leading organizations who have already joined this groundbreaking initiative.

See how the project is shifting the focus from theory and ideation to practical application of Digital CMC.

Explore the innovative pre-commercial collaboration model that members will leverage to achieve project goals.

With Project Artemis, can the industry finally crack the code on scaling Digital CMC?

Day 2 of the 2025 Digital CMC Summit opened with a major announcement: the launch of Project Artemis, a groundbreaking initiative designed to drive collaboration, standardization, and tangible impact across the industry's Digital CMC programs. Moderator Mike Stapleton, Life Sciences Luminary & Influencer, was joined by experts from several of the projects' inaugural member organizations, including Takeda and Flagship Pioneering.

Together, they discussed how the project aims to lay the foundation for a future where advanced therapies can be developed and manufactured efficiently, effectively, and at scale. With contributions from leading pharma, CDMOs, and technology companies, project members will explore practical, hands-on ways that drug developers can digitally tackle persistent inefficiencies, improve interoperability, and establish a common language for data and process management.

Watch this session to learn:

- How Project Artemis is bringing together industry leaders to accelerate the impact of Digital CMC.
- Why pre-commercial collaboration may be the key to unlocking an industry-wide Digital CMC toolkit.
- The critical role that data and process standards will play in improving CMC efficiency and regulatory success.

{{dcmc-gallery}}

Sign up below and stream the full presentation!

Session speakers

Join Project Artemis

Watch this session

Legend
Legend
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

We’re here to help you deliver

No items found.
[
QbDVision
]

Michael Stapleton

Michael Stapleton is a life sciences leader with success spanning leadership roles in software, consumables, instruments, services, consulting, and pharmaceuticals. He is a constant innovator, optimist, influencer, and digital thought leader identifying the next strategic challenge in life sciences, executing and operationalizing on high impact strategic plans to drive growth.

[
QbDVision
]

Jack Morel

[
Flagship Pioneering
]

Vijay Raju

Vijay currently leads CMC activities to deliver on Pioneering Medicines portfolio. The portfolio is built on Flagship Pioneering's bio-platforms covering multiple modalities (small molecules, biologics, cell & gene therapies). Vijay was previously in technical leadership roles at Novartis.

[
Takeda
]

Christoph Pistek

Christoph Pistek is a senior pharmaceutical executive with 20 years of experience across the full continuum of the pharmaceutical product lifecycle. With an interdisciplinary engineering background, deep expertise in technology operations, and a strong foundation in business administration, he applies a holistic and strategic approach to pervasive change.

As Vice President, Head of Sustainability and Technology, R&D at Takeda, Christoph currently is accountable for large-scale global innovation, advancing emerging capabilities and novel approaches in drug discovery and development, while ensuring alignment with Takeda's Net-Zero objectives.

His career is defined by end-to-end transformation across Research, CMC, Manufacturing, Quality, Regulatory, and Supply Chain, seamlessly integrating business excellence principles and technological advancements to accelerate efficient and scalable pharmaceutical operations.